It has been previously shown that GRd inhibits epidermal growth factor receptor (EGFR) signalling and suppresses cancer stem cell−like properties in colorectal cancer (CRC) cells, which result in the reduction of CRC metastasis.16 Here, EGFR is linked to colorectal cancer.